Abstract
We evaluated whether the pharmacokinetic parameters of indinavir differ in Koreans and Caucasians. Indinavir was administered orally to 8 healthy Koreans and 4 healthy Caucasians, and plasma indinavir levels were quantified by high performance liquid chromatography. No significant differences were observed in terms of its pharmacokinetic parameters; however, the AUC difference between the 2 groups may be significant for larger sample sizes.
| Original language | English |
|---|---|
| Pages (from-to) | 307-309 |
| Number of pages | 3 |
| Journal | Scandinavian Journal of Infectious Diseases |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2004 Jun 14 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology and Microbiology(all)
- Microbiology (medical)
- Infectious Diseases
Cite this
}
Pharmacokinetics of indinavir in Koreans and Caucasians. / Choi, Jun Yong; Chang, Kyung Hee; Park, Yoon Soo; Cho, Cheong Ho; Shin, So Youn; Song, Young Goo; Kim, June Myung.
In: Scandinavian Journal of Infectious Diseases, Vol. 36, No. 4, 14.06.2004, p. 307-309.Research output: Contribution to journal › Article
TY - JOUR
T1 - Pharmacokinetics of indinavir in Koreans and Caucasians
AU - Choi, Jun Yong
AU - Chang, Kyung Hee
AU - Park, Yoon Soo
AU - Cho, Cheong Ho
AU - Shin, So Youn
AU - Song, Young Goo
AU - Kim, June Myung
PY - 2004/6/14
Y1 - 2004/6/14
N2 - We evaluated whether the pharmacokinetic parameters of indinavir differ in Koreans and Caucasians. Indinavir was administered orally to 8 healthy Koreans and 4 healthy Caucasians, and plasma indinavir levels were quantified by high performance liquid chromatography. No significant differences were observed in terms of its pharmacokinetic parameters; however, the AUC difference between the 2 groups may be significant for larger sample sizes.
AB - We evaluated whether the pharmacokinetic parameters of indinavir differ in Koreans and Caucasians. Indinavir was administered orally to 8 healthy Koreans and 4 healthy Caucasians, and plasma indinavir levels were quantified by high performance liquid chromatography. No significant differences were observed in terms of its pharmacokinetic parameters; however, the AUC difference between the 2 groups may be significant for larger sample sizes.
UR - http://www.scopus.com/inward/record.url?scp=2642520388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2642520388&partnerID=8YFLogxK
U2 - 10.1080/00365540410019697
DO - 10.1080/00365540410019697
M3 - Article
C2 - 15198191
AN - SCOPUS:2642520388
VL - 36
SP - 307
EP - 309
JO - Infectious Diseases
JF - Infectious Diseases
SN - 2374-4235
IS - 4
ER -